tel: (646)-791-2397 info@synergycap1.com
  • Facebook
  • Twitter
  • Facebook
  • Twitter
Synergy Capital
  • Business Financing
  • Careers
  • Partner
  • Apply
  • About Us
  • Contact Us
  • Synergy Capital
  • News
Select Page

No Cure in Sight for Teva

Aug 3, 2017 | Bad Credit Loans, Business Lending, Business Loans, Capital, Finance, Non-Bank Loans, Working Capital

Don’t be fooled by the low valuation. Teva Pharmaceutical Industries is a dangerous stock to own.

Copyright © 2016 Synergy Capital. All rights reserved.